Jacques Fieschi
Chief Scientific Officer MI-mAbs
Seminars
Wednesday 25th February 2026
Evaluating Tools Enabling Early De-Risking in ADC & Antibody-Based Therapy Development
12:45 pm
- Application of single-cell resolution screening to discover new high affinity antibodies
- Real-time functional screening to ensure robust, validated leads
- Comprehensive libraries of conjugates for fast-track development of new ADCs
